JN a Pill - white round
Generic Name: propafenone
Pill with imprint JN a is White, Round and has been identified as Rythmol 300 mg. It is supplied by GlaxoSmithKline.
Rythmol is used in the treatment of Atrial Fibrillation; Wolff-Parkinson-White Syndrome; Atrial Flutter; Ventricular Tachycardia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Rythmol 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for JN a
Rythmol
- Generic Name
- propafenone
- Imprint
- JN a
- Strength
- 300 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Group I antiarrhythmics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- GlaxoSmithKline
- National Drug Code (NDC)
- 65726-0267 (Discontinued)
See also:
Xarelto
Xarelto (rivaroxaban) is a factor Xa inhibitor used to reduce the risk of blood clots and stroke in ...
Cardizem
Cardizem is used to treat hypertension (high blood pressure), angina (chest pain), and heart rhythm ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Adenocard
Adenocard is used for radionuclide myocardial perfusion study, supraventricular tachycardia ...
Lanoxin
Lanoxin (digoxin) is used to treat congestive heart failure and atrial fibrillation. Includes ...
Multaq
Multaq (dronedarone) is an antiarrhythmic medication used to treat atrial fibrillation and atrial ...
Pacerone
Pacerone is used for arrhythmia, supraventricular tachycardia, ventricular fibrillation ...
Cartia XT
Cartia XT is used for angina pectoris prophylaxis, heart failure, high blood pressure
More about Rythmol (propafenone)
- Check interactions
- Compare alternatives
- Reviews (5)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: group I antiarrhythmics
- Breastfeeding
Patient resources
Professional resources
Other formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.